{"componentChunkName":"component---src-templates-chapter-level-1-chapter-level-1-tsx","path":"/topics/pruritus-vulvae/prescribing-information/","result":{"pageContext":{"chapter":{"id":"879b4dcf-9fd5-5785-ad0a-f78ce4711c69","slug":"prescribing-information","fullItemName":"Prescribing information","depth":1,"htmlHeader":"<!-- begin field fe3fab0c-075b-438f-9d88-949474680bff --><h1>Prescribing information</h1><!-- end field fe3fab0c-075b-438f-9d88-949474680bff -->","summary":null,"htmlStringContent":"<!-- begin item 1bbea2d9-338c-453e-8b5a-88d634d299e1 --><!-- begin field 99023bd9-fbd3-4d3b-bda6-04a269c76e38 --><p>Important aspects of prescribing information relevant to primary healthcare are covered in this section specifically for the drugs recommended in this CKS topic. For further information on contraindications, cautions, drug interactions, and adverse effects, see the <a href=\"http://www.medicines.org.uk/emc\" data-hyperlink-id=\"de80356e-e10a-4075-ae34-a98c00d301e3\">electronic Medicines Compendium</a> (eMC), or the <a href=\"https://bnf.nice.org.uk/\" data-hyperlink-id=\"97badbf4-ccea-4bb3-b889-a98c00d30261\">British National Formulary</a> (BNF).</p><!-- end field 99023bd9-fbd3-4d3b-bda6-04a269c76e38 --><!-- end item 1bbea2d9-338c-453e-8b5a-88d634d299e1 -->","topic":{"id":"ab775596-ee36-566c-b99e-f26281476587","topicId":"f736b71a-0394-4d1b-81d3-89f92387f7b5","topicName":"Pruritus vulvae","slug":"pruritus-vulvae","lastRevised":"Last revised in May 2017","chapters":[{"id":"e95d24eb-aeb8-50bb-ac51-8f64aea3c30a","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"8ce4dbd7-2246-5775-ae6e-04329c1190c1","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"982a2f05-e887-58b7-b162-572ce0d3ee9f","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"38dfa294-fe36-5eaf-801f-f85edcaf9b0c","slug":"changes","fullItemName":"Changes"},{"id":"3ad7e907-7bc6-5339-9fe3-a53a943a1d5b","slug":"update","fullItemName":"Update"}]},{"id":"cfeab3a1-33f8-5401-bf2d-554006509e44","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f358fbd3-3112-597d-8318-782024ffb462","slug":"goals","fullItemName":"Goals"},{"id":"06d9f87d-ffb9-5c80-94cc-c14fabec72e4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"00abbaa1-76de-5699-92e4-c7966d120fb9","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"8c5bcf9e-40a1-5ec5-bfb3-8b61c5e05271","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"9e5947c9-06ae-527b-b39d-99249cc183b7","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"acce3106-835f-51e5-8d2a-474eb1210f06","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ede3d467-474d-5337-a3a8-69e962cdb78d","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"fed1d461-c450-5ad2-b137-ba2e7b3e25ba","slug":"definition","fullItemName":"Definition"},{"id":"69ac7b79-9272-52fb-b41a-85c62d368278","slug":"causes","fullItemName":"Causes"},{"id":"540240f7-7b5f-5dd8-9778-add2bad7a948","slug":"prevalence","fullItemName":"Prevalence"},{"id":"f32fb44d-4398-544d-8e12-40abce15c8ac","slug":"prognosis","fullItemName":"Prognosis"},{"id":"d3481fe5-fb32-5604-a01e-ef3831740641","slug":"complications","fullItemName":"Complications"}]},{"id":"ea7b6574-3e2d-5558-b3fc-e26e23ee9841","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"cb8a05d1-5735-53f1-9f3d-a8eeeaf04c43","slug":"assessment","fullItemName":"Assessment"},{"id":"d9fb23e4-f170-5e35-baf1-eb5e9eb3ef93","slug":"causes","fullItemName":"Causes"},{"id":"b2f116aa-c92b-555e-bf3d-4d48002ac082","slug":"investigations","fullItemName":"Investigations"}]},{"id":"33ec4dfa-a698-5c63-ba2b-63ff2bd4f94a","fullItemName":"Management","slug":"management","subChapters":[{"id":"39b5f2b6-2faf-5764-932b-10c3cfa35b9c","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"879b4dcf-9fd5-5785-ad0a-f78ce4711c69","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"40a71a96-802a-52ed-936a-8be2564e3966","slug":"topical-corticosteroids","fullItemName":"Topical corticosteroids"},{"id":"5a7e3fc5-3dcc-5ae7-b42c-cfd50c0b6427","slug":"hydroxyzine","fullItemName":"Hydroxyzine"}]},{"id":"e8fd8512-18b4-5a87-b393-c17a7aeea18c","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"22929cbe-97bb-51fd-848d-fb564e84e824","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"16e021f3-7a43-5db6-91c6-f2928df8f0d3","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"1e67be49-3ad9-5c49-afd7-3b4003a9e1ac","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"aa214653-3cef-5171-bc52-2abc1dca4efe","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"9f82fff6-ebda-5cfb-8995-424680c23073","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"3a44b88d-e6de-5027-a2a5-aab8d22fae10","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"2255e17a-9ac2-5004-9c32-22c36192790a","fullItemName":"References","slug":"references","subChapters":[]}]},"subChapters":[{"id":"40a71a96-802a-52ed-936a-8be2564e3966","slug":"topical-corticosteroids","fullItemName":"Topical corticosteroids","summary":""},{"id":"5a7e3fc5-3dcc-5ae7-b42c-cfd50c0b6427","slug":"hydroxyzine","fullItemName":"Hydroxyzine","summary":""}]}}},"staticQueryHashes":["3666801979"]}